Assertion: imago | /r/CapableOf | complete a phase 1/2a study of img-7289
Facets:
value: in late 2018
type: TEMPORAL
Source sentences:
text: In late 2018 Imago completed a Phase 1/2a study of IMG-7289 in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome (NCT02842827).